
Day 22 of induction therapy is important for minimal residual disease assessment by flow cytometry in childhood acute lymphoblastic leukemia
Keywords: ALL; acute lymphoblastic leukemia; MRD; minimal residual disease; FCM; flow cytometry; BM; bone marrow; LR; low risk; IR; intermediate risk; HR; high risk; EFS; event-free survival; RFS; relapse-free survival; CR; complete remission; CCR; continuous compl